Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.

BACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings. METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value...

Повний опис

Бібліографічні деталі
Автори: Walker, A, Mulenga, V, Sinyinza, F, Lishimpi, K, Nunn, A, Chintu, C, Gibb, D
Формат: Journal article
Мова:English
Опубліковано: 2006
_version_ 1826288655048638464
author Walker, A
Mulenga, V
Sinyinza, F
Lishimpi, K
Nunn, A
Chintu, C
Gibb, D
author_facet Walker, A
Mulenga, V
Sinyinza, F
Lishimpi, K
Nunn, A
Chintu, C
Gibb, D
author_sort Walker, A
collection OXFORD
description BACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings. METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value of baseline characteristics was investigated using Cox models. RESULTS: Five hundred fourteen children aged 1 to 14 (median 5.5) years contributed 607 years follow-up (maximum 2.6 years). Half were boys, and in 67%, the mother was the primary carer; at baseline, median CD4 percentage was 11% and weight was less than third percentile in 67%. One hundred sixty-five children died (27.2 per 100 years at risk; 95% confidence interval 23.3-31.6). Low weight-for-age, CD4 percentage, hemoglobin, mother as primary carer, current malnutrition, and previous hospital admissions for respiratory tract infections or recurrent severe bacterial infections were independent predictors of poorer survival, whereas oral candidiasis predicted poorer survival only when baseline CD4 percentage was not considered. Mortality rates per 100 child years of 44.5 (37.2-53.2), 14.7 (10.9-19.8), and 2.3 (0.3-16.7) were associated with new World Health Organization stages 4, 3, and 1/2, respectively, applied retrospectively; very low weight-for-age was the only staging feature for 42% of stage 4 children. CONCLUSIONS: Malnutrition and hospitalizations for respiratory/bacterial infections predict mortality independent of immunosuppression, suggesting that they capture HIV- and non-HIV-related mortality, whereas oral candidiasis is a proxy for immunosuppression.
first_indexed 2024-03-07T02:16:59Z
format Journal article
id oxford-uuid:a297b8d4-2b11-41f2-bccd-b39936a62a7c
institution University of Oxford
language English
last_indexed 2024-03-07T02:16:59Z
publishDate 2006
record_format dspace
spelling oxford-uuid:a297b8d4-2b11-41f2-bccd-b39936a62a7c2022-03-27T02:21:07ZDeterminants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a297b8d4-2b11-41f2-bccd-b39936a62a7cEnglishSymplectic Elements at Oxford2006Walker, AMulenga, VSinyinza, FLishimpi, KNunn, AChintu, CGibb, DBACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings. METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value of baseline characteristics was investigated using Cox models. RESULTS: Five hundred fourteen children aged 1 to 14 (median 5.5) years contributed 607 years follow-up (maximum 2.6 years). Half were boys, and in 67%, the mother was the primary carer; at baseline, median CD4 percentage was 11% and weight was less than third percentile in 67%. One hundred sixty-five children died (27.2 per 100 years at risk; 95% confidence interval 23.3-31.6). Low weight-for-age, CD4 percentage, hemoglobin, mother as primary carer, current malnutrition, and previous hospital admissions for respiratory tract infections or recurrent severe bacterial infections were independent predictors of poorer survival, whereas oral candidiasis predicted poorer survival only when baseline CD4 percentage was not considered. Mortality rates per 100 child years of 44.5 (37.2-53.2), 14.7 (10.9-19.8), and 2.3 (0.3-16.7) were associated with new World Health Organization stages 4, 3, and 1/2, respectively, applied retrospectively; very low weight-for-age was the only staging feature for 42% of stage 4 children. CONCLUSIONS: Malnutrition and hospitalizations for respiratory/bacterial infections predict mortality independent of immunosuppression, suggesting that they capture HIV- and non-HIV-related mortality, whereas oral candidiasis is a proxy for immunosuppression.
spellingShingle Walker, A
Mulenga, V
Sinyinza, F
Lishimpi, K
Nunn, A
Chintu, C
Gibb, D
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
title Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
title_full Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
title_fullStr Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
title_full_unstemmed Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
title_short Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
title_sort determinants of survival without antiretroviral therapy after infancy in hiv 1 infected zambian children in the chap trial
work_keys_str_mv AT walkera determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial
AT mulengav determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial
AT sinyinzaf determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial
AT lishimpik determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial
AT nunna determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial
AT chintuc determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial
AT gibbd determinantsofsurvivalwithoutantiretroviraltherapyafterinfancyinhiv1infectedzambianchildreninthechaptrial